Low-Dose Mitomycin C Decreases the Postoperative Recurrence Rate of Pterygium by Perturbing NLRP3 Inflammatory Signalling Pathway and Suppressing the Expression of Inflammatory Factors

scientific article published on 15 November 2019

Low-Dose Mitomycin C Decreases the Postoperative Recurrence Rate of Pterygium by Perturbing NLRP3 Inflammatory Signalling Pathway and Suppressing the Expression of Inflammatory Factors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2019/9472782
P932PMC publication ID6885197
P698PubMed publication ID31827916

P50authorQie GuoQ91898585
Xiang Hua QuanQ91898588
P2093author name stringYu Liang
Jun Zhao
Li-Na Wei
Xiao Li
Xiao-Lei Zhang
Xiang-Peng Li
Meng-Na Cui
P2860cites workThe inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-betaQ24305136
Mitomycin C in pterygium treatmentQ26751130
Evaluation of transforming growth factor-beta1 gene expression in pterygium tissue of atopic patients.Q51567819
Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.Q54684971
Risk Analysis in the Development of PterygiaQ56227180
[Blood vessel multiply and significance of expression of Cox-2, VEGF in pterygium]Q80180662
Cutaneous manifestations associated with antiphospholipid antibodiesQ80545644
Comparison of limbal-conjunctival autograft and intraoperative 0.02% mitomycin-C for treatment of primary pterygiumQ80762414
Antifibrotic effect of pirfenidone on human pterygium fibroblastsQ87053005
Endocan Overexpression in PterygiumQ87837112
Serious complications of topical mitomycin-C after pterygium surgeryQ28317596
Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathyQ28391260
Epidemiology of pterygium. A reviewQ34110266
Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.Q34444720
Young patient's age determines pterygium recurrence after surgeryQ35665260
The role of IL-6 and STAT3 in inflammation and cancerQ36274467
High frequency of squamous intraepithelial neoplasia in pterygium related to low ultraviolet light exposureQ37004727
Multiple pterygium syndrome: Challenge for anesthesiologistQ37028243
Correlations Between Histopathologic Changes and Clinical Features in PterygiaQ37051043
Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistanceQ37296393
Chronic inflammatory cells and damaged limbal cells in pterygiumQ37298939
Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.Q37312116
Inflammasomes and their roles in health and diseaseQ38043048
The NLRP3 inflammasome: role in airway inflammation.Q38151886
A New Conjunctival Free Flap Design Technique for Pterygium Surgery: Stamp TechniqueQ38577219
Mechanism and Regulation of NLRP3 Inflammasome ActivationQ38964695
Pingueculae and pterygiaQ39530716
The expression and significance of p53 protein and Ki-67 protein in pterygiumQ40861007
Identification of human papillomavirus in pterygiumQ41342708
Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patientsQ42435255
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectpterygiumQ1862972
P304page(s)9472782
P577publication date2019-11-15
P1433published inJournal of OphthalmologyQ26842872
P1476titleLow-Dose Mitomycin C Decreases the Postoperative Recurrence Rate of Pterygium by Perturbing NLRP3 Inflammatory Signalling Pathway and Suppressing the Expression of Inflammatory Factors
P478volume2019

Search more.